SOLAZONE 1.5 GM

SOLAZONE 1.5GM DISCRIPTION: Combination is more active than cefoxitine plus clindamycin against anaerobic bacteria. Exhibits more potent antimicrobial activity than cefoperazone against beta-lactamase producing E.Coli. Useful in treatment of nosocomial infection caused by multidrug-resistant pathogens in neonates. Safe and well tolerable profile INDICATION -: Meningitis Urinary Tract Infections Septicaemia Bone and Joint Infections Intra-abdominal Infections Pelvic Inflammatory Disease Respiratory Tract Infections